About this Activity

Kidney Week 2020 Reimagined featured 16 innovative educational symposia that educated participants about specific areas of nephrology. View the videos presented during the annual meeting October 22 – 25, 2020 below.

This is not a Continuing Education (CE) activity.

Available Educational Symposia

• Session: "Pumping" Iron for CKD
  Sponsor: Support is provided by an educational grant from Akebia Therapeutics, Inc.
• Session: A Practical Approach to Using SGLT2 Inhibitors for Cardiorenal Protection
  Sponsor: Support is provided by an educational grant from AstraZeneca Pharmaceuticals.
• Session: Autosomal Dominant Polycystic Kidney Disease: Risk Assessment and Management
  Sponsor: Support is provided by an educational grant from Otsuka America Pharmaceutical, Inc.
• Session: Causes and Treatments for CKD-Associated Pruritus
  Sponsor: Support is provided by an educational grant from Cara Therapeutics, Inc.
• Session: Diagnostic Controversies in Transplantation: Of Biomarkers and Biopsies
  Sponsor: Support is provided by an educational grant from CareDx.
• Session: Hepatorenal Syndrome Type 1: Diagnosis Methods and Management
  Sponsor: Support is provided by an educational grant from Mallinckrodt LLC.
• Session: HIF-PH Inhibitors: Moving Beyond Erythropoietin and Iron Deficiency
  Sponsor: Support is provided by an educational grant from Akebia Therapeutics, Inc. and Otsuka America Pharmaceutical, Inc.
• Session: Moving the Needle: Updated Evidence on Metabolic Acidosis
  Sponsor: Support is provided by an educational grant from Tricida, Inc.
• Session: New Era of Anemia of CKD After the Nobel Prize
  Sponsor: Support is provided by an educational grant from AstraZeneca Pharmaceuticals LP in collaboration with FibroGen.
• Session: Novel Insights into the Diagnosis and Management of Atypical Hemolytic Uremic Syndrome
  Sponsor: Support is provided by an educational grant from Alexion Pharmaceuticals, Inc.
• Session: Novel Therapeutic Options in Hyperkalemia
  Sponsor: Support is provided by an educational grant from AstraZeneca Pharmaceuticals.
• Session: Opportunities and Barriers in Diagnosing CKD of Uncertain Etiology
  Sponsor: Support is provided by an educational grant from Natera.
• Session: Phosphorus Control in Hemodialysis: What's the Optimal Strategy?
  Sponsor: Support is provided by an educational grant from Fresenius Medical Care Renal Therapies Group.
• Session: Removal of Large Middle Molecular Uremic Toxins: Room for Innovation
  Sponsor: Support is provided by an educational grant from Baxter Healthcare Corporation.
• Session: Strategies to Control Chronic Hyperkalemia in Patients with CKD and ESRD
  Sponsor: Support is provided by an educational grant from Relypsa, Inc., A Vifor Pharma Group Company.
• Session: Targeting Complement in ANCA-Associated Vasculitis
  Sponsor: Support is provided by an educational grant from ChemoCentryx, Inc.